ASHPOfficial

Pharmacists have a role in managing anticoagulant therapy in acutely ill hospitalized patients at risk for VTE, including protocol development and research, identifying unmet need and the value of prophylaxis in medically ill patients, and implementing practical DVT and PE prevention strategies. Consensus guidelines (e.g., COVID-19 ISTH 2020, COVID-19 ACC) have provided some guidance for COVID-19 infection and the connection to deep vein thrombosis and pulmonary embolism.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

There is a gap between supply and demand for available organ transplants, resulting in a substantial impact on public health. Listen as transplant pharmacists discuss April’s National Donate Life Month and how pharmacists and pharmacy students have a fundamental role in promoting organ donation awareness. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join our content matter experts from the 2020 Midyear Clinical Meeting as they identify optimization strategies for pain and sedation medication management in mechanically ventilated COVID-19 patients, describe the patient-specific considerations when optimizing pain and sedation management and how to address the barriers of ICU patient care. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode of the Pharmacy Leaders series podcast, host, Sara White, MS, FASHP, discusses finding mentors to help you grow, learn and develop as a leader and putting those leadership traits into practice.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

During this podcast, speakers describe post-operative nausea and vomiting (PONV) risk stratification and synthesize the latest PONV guidelines to guide appropriate medications and non-pharmacologic therapies. They also explore the consequences of PONV and its effects on both the patient and the healthcare system. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician

This podcast provides members an overview of the impact of a recent federal court decision on PGY-1 residency program disallowances. We’ll cover what the ruling means for programs under audit and what comes next with CMS advocacy. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Both CCM and RPM are attractive opportunities for pharmacists to improve patient centered outcomes in collaboration with supervising providers. Physician Fee Schedule (PFS) changes and the ongoing Public Health Emergency (PHE) present both opportunities and barriers for growth and implementation. The purpose of this Podcast is to highlight examples of how pharmacists have navigated these changes and implementation stages so far.  

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician

Pharmacists have a role in managing anticoagulant therapy in acutely ill hospitalized patients at risk for VTE, including protocol development and research, identifying an unmet need and the value of prophylaxis in medically ill patients, and implementing practical DVT and PE prevention strategies. Consensus guidelines (e.g., COVID-19 ISTH 2020, COVID-19 ACC) have provided some guidance for COVID-19 infection and the connection to deep vein thrombosis and pulmonary embolism. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician

In this interprofessional conversation, expert faculty discuss evidence supporting quantitative neuromuscular monitoring (NMM) versus qualitative NMM, which quantitative monitors are available in the U.S., and evidence/guidelines supporting monitoring preferences. NMM and complete neuromuscular blockade (NMB) reversal in patients at high risk for residual NMB (rNMB), including elderly and obese patients, will also be discussed. 

To learn more about neuromuscular blockade and reversal visit www.ashpadvantage.com/nmbreversal/.

This podcast is provided by ASHP and supported by Merck. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician

This podcast will explore considerations for preceptors, experiential sites, and pharmacy students for IPPE and APPE learning experiences during the COVID-19 pandemic.  Speakers will review strategies to ensure consistent learning opportunities and also discuss methods that were implemented in the event a learner or preceptor tested positive for coronavirus.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.